GSK buys COVID and flu vaccines from shrinking CureVac company
British drugmaker GSK on Wednesday bought out partner CureVac from its alliance to develop influenza vaccines and COVID-19, boosting its RNA informatics expertise and expanding the German biotech company’s financial capabilities.
ПОПУЛЯРНЫЕ ПОСТЫ
UK sets new climate target for 2035
Ноябрь 13, 2024
Children go back to school after Valencia floods
Ноябрь 13, 2024
Researchers document huge decline in African elephants
Ноябрь 13, 2024
Mission: Impossible 8 title revealed
Ноябрь 13, 2024
ПОДПИСЫВАЙТЕСЬ НА НАС
ПРЯМАЯ ТРАНСЛЯЦИЯ